Skip to content
OpenCapital
Get started

LivaNova LIVN Free cash flow margin

Free cash flow margin at other companies

Abbott logo
AbbottABT
16.3%+0.6pp
Haemonetics logo
HaemoneticsHAE
19.5%+9.1pp
Medtronic logo
MedtronicMDT
14.9%-0.5pp
ResMed logo
ResMedRMD
31.7%+0.4pp
Boston Scientific logo
Boston ScientificBSX
16.9%-0.3pp
Stryker logo
StrykerSYK
18.1%+2.7pp

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S3×+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

free cash flow/total revenue=11.2%

Based on trailing twelve months.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's free cash flow margin?
LivaNova (LIVN) reported free cash flow margin of 11.2% in Q1 2026.
How has LivaNova's free cash flow margin changed year-over-year?
LivaNova's free cash flow margin decreased by 1.5% year-over-year, from 11.4% to 11.2%.
What is the long-term trend for LivaNova's free cash flow margin?
Over 3 years (2021 to 2025), LivaNova's free cash flow margin has grown at a 18.8% compound annual growth rate (CAGR), from 7.4% to 12.5%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.